Researchers at the University of Cambridge have discovered a possible explanation for why aspirin may help stop cancer from spreading. The study found that aspirin reduces a clotting factor called thromboxane A2, which triggers a protein called ARHGEF1 and suppresses immune cells known as T cells. By stopping this protein, aspirin’s anti-metastatic activity is enhanced. While the findings are promising, doctors caution against patients starting an aspirin regimen without consulting their physician due to increased risk of gastrointestinal bleeding. However, further research and clinical trials may one day show that aspirin therapy can benefit certain cancer patients, making it a potentially more accessible and affordable treatment option.
Source: https://people.com/this-medicine-cabinet-staple-may-stop-cancer-from-spreading-11692417